These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10931556)

  • 21. Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study.
    Pagano B; Virno A; Mattia CA; Mayol L; Randazzo A; Giancola C
    Biochimie; 2008 Aug; 90(8):1224-32. PubMed ID: 18420038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quadruplex DNA crystal structures and drug design.
    Neidle S; Parkinson GN
    Biochimie; 2008 Aug; 90(8):1184-96. PubMed ID: 18395014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Energetics of sequence-specific protein-DNA association: binding of integrase Tn916 to its target DNA.
    Milev S; Gorfe AA; Karshikoff A; Clubb RT; Bosshard HR; Jelesarov I
    Biochemistry; 2003 Apr; 42(12):3481-91. PubMed ID: 12653552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of anthracene-based DNA binders.
    Duff MR; Mudhivarthi VK; Kumar CV
    J Phys Chem B; 2009 Feb; 113(6):1710-21. PubMed ID: 19193168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
    Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
    Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double chain reversal loop and two diagonal loops define the architecture of a unimolecular DNA quadruplex containing a pair of stacked G(syn)-G(syn)-G(anti)-G(anti) tetrads flanked by a G-(T-T) Triad and a T-T-T triple.
    Kuryavyi V; Majumdar A; Shallop A; Chernichenko N; Skripkin E; Jones R; Patel DJ
    J Mol Biol; 2001 Jun; 310(1):181-94. PubMed ID: 11419945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are AM1 ligand-protein binding enthalpies good enough for use in the rational design of new drugs?
    Villar R; Gil MJ; García JI; Martínez-Merino V
    J Comput Chem; 2005 Oct; 26(13):1347-58. PubMed ID: 16021597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm.
    Buchmueller KL; Bailey SL; Matthews DA; Taherbhai ZT; Register JK; Davis ZS; Bruce CD; O'Hare C; Hartley JA; Lee M
    Biochemistry; 2006 Nov; 45(45):13551-65. PubMed ID: 17087509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids.
    Hardin CC; Perry AG; White K
    Biopolymers; 2000-2001; 56(3):147-94. PubMed ID: 11745110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energetic diversity of DNA minor-groove recognition by small molecules displayed through some model ligand-DNA systems.
    Lah J; Vesnaver G
    J Mol Biol; 2004 Sep; 342(1):73-89. PubMed ID: 15313608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA nanomachines and nanostructures involving quadruplexes.
    Alberti P; Bourdoncle A; Saccà B; Lacroix L; Mergny JL
    Org Biomol Chem; 2006 Sep; 4(18):3383-91. PubMed ID: 17036128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design.
    Velazquez-Campoy A; Kiso Y; Freire E
    Arch Biochem Biophys; 2001 Jun; 390(2):169-75. PubMed ID: 11396919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemo-genetic optimization of DNA recognition by metallodrugs using a presenter-protein strategy.
    Zimbron JM; Sardo A; Heinisch T; Wohlschlager T; Gradinaru J; Massa C; Schirmer T; Creus M; Ward TR
    Chemistry; 2010 Nov; 16(43):12883-9. PubMed ID: 20878805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.
    Davis AM; Teague SJ; Kleywegt GJ
    Angew Chem Int Ed Engl; 2003 Jun; 42(24):2718-36. PubMed ID: 12820253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization to obtain protein-ligand complexes for structure-aided drug design.
    Danley DE
    Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):569-75. PubMed ID: 16699182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability and structure of telomeric DNA sequences forming quadruplexes containing four G-tetrads with different topological arrangements.
    Petraccone L; Erra E; Esposito V; Randazzo A; Mayol L; Nasti L; Barone G; Giancola C
    Biochemistry; 2004 Apr; 43(16):4877-84. PubMed ID: 15096057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of drug-DNA interactions: virtual screening to structure-based design.
    Ma DL; Chan DS; Lee P; Kwan MH; Leung CH
    Biochimie; 2011 Aug; 93(8):1252-66. PubMed ID: 21514356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding site detection and druggability index from first principles.
    Seco J; Luque FJ; Barril X
    J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.